The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Minimally Invasive Treatment of Lung Cancer Market Research Report 2025
Synopsis
The minimally invasive treatment method for lung cancer is to cut relatively small wounds around the lung, and then perform local resection through thoracoscopy. The skin injury is relatively small during the operation, and the recovery period after the operation will be very short.
The global Minimally Invasive Treatment of Lung Cancer market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Minimally Invasive Treatment of Lung Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Minimally Invasive Treatment of Lung Cancer.
Report Scope
The Minimally Invasive Treatment of Lung Cancer market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Minimally Invasive Treatment of Lung Cancer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Minimally Invasive Treatment of Lung Cancer companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic
Olympus
LungCare
Broncus
Intuitive Surgica
Auris Health
Angiodynamics
Boston Scientific
Smith and Nephew
VISON Medical
Nanjing MICRO-TECH
Segment by Type
Lung Tumor Ablation
Lung Tumor Embolization
Segment by Application
Hospitals
Ambulatory Surgical Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Minimally Invasive Treatment of Lung Cancer companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The minimally invasive treatment method for lung cancer is to cut relatively small wounds around the lung, and then perform local resection through thoracoscopy. The skin injury is relatively small during the operation, and the recovery period after the operation will be very short.
The global Minimally Invasive Treatment of Lung Cancer market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Minimally Invasive Treatment of Lung Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Minimally Invasive Treatment of Lung Cancer.
Report Scope
The Minimally Invasive Treatment of Lung Cancer market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Minimally Invasive Treatment of Lung Cancer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Minimally Invasive Treatment of Lung Cancer companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic
Olympus
LungCare
Broncus
Intuitive Surgica
Auris Health
Angiodynamics
Boston Scientific
Smith and Nephew
VISON Medical
Nanjing MICRO-TECH
Segment by Type
Lung Tumor Ablation
Lung Tumor Embolization
Segment by Application
Hospitals
Ambulatory Surgical Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Minimally Invasive Treatment of Lung Cancer companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Minimally Invasive Treatment of Lung Cancer Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Lung Tumor Ablation
1.2.3 Lung Tumor Embolization
1.3 Market by Application
1.3.1 Global Minimally Invasive Treatment of Lung Cancer Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Minimally Invasive Treatment of Lung Cancer Market Perspective (2019-2030)
2.2 Minimally Invasive Treatment of Lung Cancer Growth Trends by Region
2.2.1 Global Minimally Invasive Treatment of Lung Cancer Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Minimally Invasive Treatment of Lung Cancer Historic Market Size by Region (2019-2024)
2.2.3 Minimally Invasive Treatment of Lung Cancer Forecasted Market Size by Region (2025-2030)
2.3 Minimally Invasive Treatment of Lung Cancer Market Dynamics
2.3.1 Minimally Invasive Treatment of Lung Cancer Industry Trends
2.3.2 Minimally Invasive Treatment of Lung Cancer Market Drivers
2.3.3 Minimally Invasive Treatment of Lung Cancer Market Challenges
2.3.4 Minimally Invasive Treatment of Lung Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Minimally Invasive Treatment of Lung Cancer Players by Revenue
3.1.1 Global Top Minimally Invasive Treatment of Lung Cancer Players by Revenue (2019-2024)
3.1.2 Global Minimally Invasive Treatment of Lung Cancer Revenue Market Share by Players (2019-2024)
3.2 Global Minimally Invasive Treatment of Lung Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Minimally Invasive Treatment of Lung Cancer Revenue
3.4 Global Minimally Invasive Treatment of Lung Cancer Market Concentration Ratio
3.4.1 Global Minimally Invasive Treatment of Lung Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Minimally Invasive Treatment of Lung Cancer Revenue in 2023
3.5 Minimally Invasive Treatment of Lung Cancer Key Players Head office and Area Served
3.6 Key Players Minimally Invasive Treatment of Lung Cancer Product Solution and Service
3.7 Date of Enter into Minimally Invasive Treatment of Lung Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Minimally Invasive Treatment of Lung Cancer Breakdown Data by Type
4.1 Global Minimally Invasive Treatment of Lung Cancer Historic Market Size by Type (2019-2024)
4.2 Global Minimally Invasive Treatment of Lung Cancer Forecasted Market Size by Type (2025-2030)
5 Minimally Invasive Treatment of Lung Cancer Breakdown Data by Application
5.1 Global Minimally Invasive Treatment of Lung Cancer Historic Market Size by Application (2019-2024)
5.2 Global Minimally Invasive Treatment of Lung Cancer Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Minimally Invasive Treatment of Lung Cancer Market Size (2019-2030)
6.2 North America Minimally Invasive Treatment of Lung Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Minimally Invasive Treatment of Lung Cancer Market Size by Country (2019-2024)
6.4 North America Minimally Invasive Treatment of Lung Cancer Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Minimally Invasive Treatment of Lung Cancer Market Size (2019-2030)
7.2 Europe Minimally Invasive Treatment of Lung Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Minimally Invasive Treatment of Lung Cancer Market Size by Country (2019-2024)
7.4 Europe Minimally Invasive Treatment of Lung Cancer Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Minimally Invasive Treatment of Lung Cancer Market Size (2019-2030)
8.2 Asia-Pacific Minimally Invasive Treatment of Lung Cancer Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Minimally Invasive Treatment of Lung Cancer Market Size by Region (2019-2024)
8.4 Asia-Pacific Minimally Invasive Treatment of Lung Cancer Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Minimally Invasive Treatment of Lung Cancer Market Size (2019-2030)
9.2 Latin America Minimally Invasive Treatment of Lung Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Minimally Invasive Treatment of Lung Cancer Market Size by Country (2019-2024)
9.4 Latin America Minimally Invasive Treatment of Lung Cancer Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Size (2019-2030)
10.2 Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Size by Country (2019-2024)
10.4 Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Detail
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Minimally Invasive Treatment of Lung Cancer Introduction
11.1.4 Medtronic Revenue in Minimally Invasive Treatment of Lung Cancer Business (2019-2024)
11.1.5 Medtronic Recent Development
11.2 Olympus
11.2.1 Olympus Company Detail
11.2.2 Olympus Business Overview
11.2.3 Olympus Minimally Invasive Treatment of Lung Cancer Introduction
11.2.4 Olympus Revenue in Minimally Invasive Treatment of Lung Cancer Business (2019-2024)
11.2.5 Olympus Recent Development
11.3 LungCare
11.3.1 LungCare Company Detail
11.3.2 LungCare Business Overview
11.3.3 LungCare Minimally Invasive Treatment of Lung Cancer Introduction
11.3.4 LungCare Revenue in Minimally Invasive Treatment of Lung Cancer Business (2019-2024)
11.3.5 LungCare Recent Development
11.4 Broncus
11.4.1 Broncus Company Detail
11.4.2 Broncus Business Overview
11.4.3 Broncus Minimally Invasive Treatment of Lung Cancer Introduction
11.4.4 Broncus Revenue in Minimally Invasive Treatment of Lung Cancer Business (2019-2024)
11.4.5 Broncus Recent Development
11.5 Intuitive Surgica
11.5.1 Intuitive Surgica Company Detail
11.5.2 Intuitive Surgica Business Overview
11.5.3 Intuitive Surgica Minimally Invasive Treatment of Lung Cancer Introduction
11.5.4 Intuitive Surgica Revenue in Minimally Invasive Treatment of Lung Cancer Business (2019-2024)
11.5.5 Intuitive Surgica Recent Development
11.6 Auris Health
11.6.1 Auris Health Company Detail
11.6.2 Auris Health Business Overview
11.6.3 Auris Health Minimally Invasive Treatment of Lung Cancer Introduction
11.6.4 Auris Health Revenue in Minimally Invasive Treatment of Lung Cancer Business (2019-2024)
11.6.5 Auris Health Recent Development
11.7 Angiodynamics
11.7.1 Angiodynamics Company Detail
11.7.2 Angiodynamics Business Overview
11.7.3 Angiodynamics Minimally Invasive Treatment of Lung Cancer Introduction
11.7.4 Angiodynamics Revenue in Minimally Invasive Treatment of Lung Cancer Business (2019-2024)
11.7.5 Angiodynamics Recent Development
11.8 Boston Scientific
11.8.1 Boston Scientific Company Detail
11.8.2 Boston Scientific Business Overview
11.8.3 Boston Scientific Minimally Invasive Treatment of Lung Cancer Introduction
11.8.4 Boston Scientific Revenue in Minimally Invasive Treatment of Lung Cancer Business (2019-2024)
11.8.5 Boston Scientific Recent Development
11.9 Smith and Nephew
11.9.1 Smith and Nephew Company Detail
11.9.2 Smith and Nephew Business Overview
11.9.3 Smith and Nephew Minimally Invasive Treatment of Lung Cancer Introduction
11.9.4 Smith and Nephew Revenue in Minimally Invasive Treatment of Lung Cancer Business (2019-2024)
11.9.5 Smith and Nephew Recent Development
11.10 VISON Medical
11.10.1 VISON Medical Company Detail
11.10.2 VISON Medical Business Overview
11.10.3 VISON Medical Minimally Invasive Treatment of Lung Cancer Introduction
11.10.4 VISON Medical Revenue in Minimally Invasive Treatment of Lung Cancer Business (2019-2024)
11.10.5 VISON Medical Recent Development
11.11 Nanjing MICRO-TECH
11.11.1 Nanjing MICRO-TECH Company Detail
11.11.2 Nanjing MICRO-TECH Business Overview
11.11.3 Nanjing MICRO-TECH Minimally Invasive Treatment of Lung Cancer Introduction
11.11.4 Nanjing MICRO-TECH Revenue in Minimally Invasive Treatment of Lung Cancer Business (2019-2024)
11.11.5 Nanjing MICRO-TECH Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Minimally Invasive Treatment of Lung Cancer Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Lung Tumor Ablation
Table 3. Key Players of Lung Tumor Embolization
Table 4. Global Minimally Invasive Treatment of Lung Cancer Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Minimally Invasive Treatment of Lung Cancer Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Minimally Invasive Treatment of Lung Cancer Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Minimally Invasive Treatment of Lung Cancer Market Share by Region (2019-2024)
Table 8. Global Minimally Invasive Treatment of Lung Cancer Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Minimally Invasive Treatment of Lung Cancer Market Share by Region (2025-2030)
Table 10. Minimally Invasive Treatment of Lung Cancer Market Trends
Table 11. Minimally Invasive Treatment of Lung Cancer Market Drivers
Table 12. Minimally Invasive Treatment of Lung Cancer Market Challenges
Table 13. Minimally Invasive Treatment of Lung Cancer Market Restraints
Table 14. Global Minimally Invasive Treatment of Lung Cancer Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Minimally Invasive Treatment of Lung Cancer Market Share by Players (2019-2024)
Table 16. Global Top Minimally Invasive Treatment of Lung Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Minimally Invasive Treatment of Lung Cancer as of 2023)
Table 17. Ranking of Global Top Minimally Invasive Treatment of Lung Cancer Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Minimally Invasive Treatment of Lung Cancer Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Minimally Invasive Treatment of Lung Cancer Product Solution and Service
Table 21. Date of Enter into Minimally Invasive Treatment of Lung Cancer Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Minimally Invasive Treatment of Lung Cancer Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Minimally Invasive Treatment of Lung Cancer Revenue Market Share by Type (2019-2024)
Table 25. Global Minimally Invasive Treatment of Lung Cancer Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Minimally Invasive Treatment of Lung Cancer Revenue Market Share by Type (2025-2030)
Table 27. Global Minimally Invasive Treatment of Lung Cancer Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Minimally Invasive Treatment of Lung Cancer Revenue Market Share by Application (2019-2024)
Table 29. Global Minimally Invasive Treatment of Lung Cancer Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Minimally Invasive Treatment of Lung Cancer Revenue Market Share by Application (2025-2030)
Table 31. North America Minimally Invasive Treatment of Lung Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Minimally Invasive Treatment of Lung Cancer Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Minimally Invasive Treatment of Lung Cancer Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Minimally Invasive Treatment of Lung Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Minimally Invasive Treatment of Lung Cancer Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Minimally Invasive Treatment of Lung Cancer Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Minimally Invasive Treatment of Lung Cancer Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Minimally Invasive Treatment of Lung Cancer Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Minimally Invasive Treatment of Lung Cancer Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Minimally Invasive Treatment of Lung Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Minimally Invasive Treatment of Lung Cancer Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Minimally Invasive Treatment of Lung Cancer Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Size by Country (2025-2030) & (US$ Million)
Table 46. Medtronic Company Detail
Table 47. Medtronic Business Overview
Table 48. Medtronic Minimally Invasive Treatment of Lung Cancer Product
Table 49. Medtronic Revenue in Minimally Invasive Treatment of Lung Cancer Business (2019-2024) & (US$ Million)
Table 50. Medtronic Recent Development
Table 51. Olympus Company Detail
Table 52. Olympus Business Overview
Table 53. Olympus Minimally Invasive Treatment of Lung Cancer Product
Table 54. Olympus Revenue in Minimally Invasive Treatment of Lung Cancer Business (2019-2024) & (US$ Million)
Table 55. Olympus Recent Development
Table 56. LungCare Company Detail
Table 57. LungCare Business Overview
Table 58. LungCare Minimally Invasive Treatment of Lung Cancer Product
Table 59. LungCare Revenue in Minimally Invasive Treatment of Lung Cancer Business (2019-2024) & (US$ Million)
Table 60. LungCare Recent Development
Table 61. Broncus Company Detail
Table 62. Broncus Business Overview
Table 63. Broncus Minimally Invasive Treatment of Lung Cancer Product
Table 64. Broncus Revenue in Minimally Invasive Treatment of Lung Cancer Business (2019-2024) & (US$ Million)
Table 65. Broncus Recent Development
Table 66. Intuitive Surgica Company Detail
Table 67. Intuitive Surgica Business Overview
Table 68. Intuitive Surgica Minimally Invasive Treatment of Lung Cancer Product
Table 69. Intuitive Surgica Revenue in Minimally Invasive Treatment of Lung Cancer Business (2019-2024) & (US$ Million)
Table 70. Intuitive Surgica Recent Development
Table 71. Auris Health Company Detail
Table 72. Auris Health Business Overview
Table 73. Auris Health Minimally Invasive Treatment of Lung Cancer Product
Table 74. Auris Health Revenue in Minimally Invasive Treatment of Lung Cancer Business (2019-2024) & (US$ Million)
Table 75. Auris Health Recent Development
Table 76. Angiodynamics Company Detail
Table 77. Angiodynamics Business Overview
Table 78. Angiodynamics Minimally Invasive Treatment of Lung Cancer Product
Table 79. Angiodynamics Revenue in Minimally Invasive Treatment of Lung Cancer Business (2019-2024) & (US$ Million)
Table 80. Angiodynamics Recent Development
Table 81. Boston Scientific Company Detail
Table 82. Boston Scientific Business Overview
Table 83. Boston Scientific Minimally Invasive Treatment of Lung Cancer Product
Table 84. Boston Scientific Revenue in Minimally Invasive Treatment of Lung Cancer Business (2019-2024) & (US$ Million)
Table 85. Boston Scientific Recent Development
Table 86. Smith and Nephew Company Detail
Table 87. Smith and Nephew Business Overview
Table 88. Smith and Nephew Minimally Invasive Treatment of Lung Cancer Product
Table 89. Smith and Nephew Revenue in Minimally Invasive Treatment of Lung Cancer Business (2019-2024) & (US$ Million)
Table 90. Smith and Nephew Recent Development
Table 91. VISON Medical Company Detail
Table 92. VISON Medical Business Overview
Table 93. VISON Medical Minimally Invasive Treatment of Lung Cancer Product
Table 94. VISON Medical Revenue in Minimally Invasive Treatment of Lung Cancer Business (2019-2024) & (US$ Million)
Table 95. VISON Medical Recent Development
Table 96. Nanjing MICRO-TECH Company Detail
Table 97. Nanjing MICRO-TECH Business Overview
Table 98. Nanjing MICRO-TECH Minimally Invasive Treatment of Lung Cancer Product
Table 99. Nanjing MICRO-TECH Revenue in Minimally Invasive Treatment of Lung Cancer Business (2019-2024) & (US$ Million)
Table 100. Nanjing MICRO-TECH Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Minimally Invasive Treatment of Lung Cancer Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Minimally Invasive Treatment of Lung Cancer Market Share by Type: 2023 VS 2030
Figure 3. Lung Tumor Ablation Features
Figure 4. Lung Tumor Embolization Features
Figure 5. Global Minimally Invasive Treatment of Lung Cancer Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Minimally Invasive Treatment of Lung Cancer Market Share by Application: 2023 VS 2030
Figure 7. Hospitals Case Studies
Figure 8. Ambulatory Surgical Centers Case Studies
Figure 9. Minimally Invasive Treatment of Lung Cancer Report Years Considered
Figure 10. Global Minimally Invasive Treatment of Lung Cancer Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global Minimally Invasive Treatment of Lung Cancer Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Minimally Invasive Treatment of Lung Cancer Market Share by Region: 2023 VS 2030
Figure 13. Global Minimally Invasive Treatment of Lung Cancer Market Share by Players in 2023
Figure 14. Global Top Minimally Invasive Treatment of Lung Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Minimally Invasive Treatment of Lung Cancer as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by Minimally Invasive Treatment of Lung Cancer Revenue in 2023
Figure 16. North America Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America Minimally Invasive Treatment of Lung Cancer Market Share by Country (2019-2030)
Figure 18. United States Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Canada Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Europe Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Minimally Invasive Treatment of Lung Cancer Market Share by Country (2019-2030)
Figure 22. Germany Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. France Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. U.K. Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Italy Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Russia Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Nordic Countries Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Minimally Invasive Treatment of Lung Cancer Market Share by Region (2019-2030)
Figure 30. China Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Japan Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. South Korea Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Southeast Asia Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. India Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Australia Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Latin America Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Minimally Invasive Treatment of Lung Cancer Market Share by Country (2019-2030)
Figure 38. Mexico Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Brazil Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Share by Country (2019-2030)
Figure 42. Turkey Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Saudi Arabia Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Medtronic Revenue Growth Rate in Minimally Invasive Treatment of Lung Cancer Business (2019-2024)
Figure 45. Olympus Revenue Growth Rate in Minimally Invasive Treatment of Lung Cancer Business (2019-2024)
Figure 46. LungCare Revenue Growth Rate in Minimally Invasive Treatment of Lung Cancer Business (2019-2024)
Figure 47. Broncus Revenue Growth Rate in Minimally Invasive Treatment of Lung Cancer Business (2019-2024)
Figure 48. Intuitive Surgica Revenue Growth Rate in Minimally Invasive Treatment of Lung Cancer Business (2019-2024)
Figure 49. Auris Health Revenue Growth Rate in Minimally Invasive Treatment of Lung Cancer Business (2019-2024)
Figure 50. Angiodynamics Revenue Growth Rate in Minimally Invasive Treatment of Lung Cancer Business (2019-2024)
Figure 51. Boston Scientific Revenue Growth Rate in Minimally Invasive Treatment of Lung Cancer Business (2019-2024)
Figure 52. Smith and Nephew Revenue Growth Rate in Minimally Invasive Treatment of Lung Cancer Business (2019-2024)
Figure 53. VISON Medical Revenue Growth Rate in Minimally Invasive Treatment of Lung Cancer Business (2019-2024)
Figure 54. Nanjing MICRO-TECH Revenue Growth Rate in Minimally Invasive Treatment of Lung Cancer Business (2019-2024)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
